PuSH - Publikationsserver des Helmholtz Zentrums München

MicroRNAs of Epstein-Barr virus control innate and adaptive anti-viral immunity.

J. Virol. 91:e01667-16 (2017)
Verlagsversion Postprint DOI PMC
Open Access Green
More than 90% of humanity is infected with Epstein-Barr virus (EBV) lifelong. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known that act as immunoevasins preventing or reducing recognition of EBV-infected cells. Only recently, microRNAs of EBV were identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory miRNAs of herpesviruses.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.663
1.131
39
38
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cancer ; Human Herpesviruses ; Immune Evasion ; Immune Surveillance ; Microrna; T-cell Responses; Noncoding Rnas; Nasopharyngeal Carcinoma; Encoded Micrornas; Viral Mirnas; Ebv; Expression; Infection; Target; Modulation
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0022-538X
e-ISSN 1098-5514
Zeitschrift Journal of Virology
Quellenangaben Band: 91, Heft: 16, Seiten: , Artikelnummer: e01667-16 Supplement: ,
Verlag American Society for Microbiology (ASM)
Verlagsort Washington
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501500-001
Scopus ID 85026322795
PubMed ID 28592533
Erfassungsdatum 2017-07-17